Wrap Text
Results of the General Meeting and update on Equity Raise
Ascendis Health Limited
(Registration number 2008/005856/06)
(Incorporated in the Republic of South Africa)
JSE share code: ASC
ISIN: ZAE000185005
(“Ascendis of “the Company”)
RESULTS OF THE GENERAL MEETING AND UPDATE ON EQUITY RAISE
1. General Meeting
Ascendis shareholders are advised that at the General Meeting of members held at Block A Silverwood, Steenberg
Office Park, Silverwood Close, Tokai, Cape Town, 7945, at 09:00 on Thursday, 11 August 2016, all the ordinary and
special resolutions as proposed in the Notice of the General Meeting were approved by the requisite majority of
members. In this regard, Ascendis confirms the voting results from the General Meeting as follows:
% Number
Total number of shares that could be voted at meeting 100% 298,873,785
Total number of shares present/represented including proxies at meeting 65.28% 195,094,108
Total number of members present/presented by representation 68
Votes in Votes Abstain Shares
Favour Against voted
Special Resolution Number 1 180,706,626 14,387,482 0 195,094,108
General authority to issue shares of the Company for cash 92.63% 7.37% 0.00% 100.00%
Ordinary Resolution Number 1 195,094,108 0 0 195,094,108
Approval of the implementation of the Scitec Transaction as 100.00% 0.00% 0.00% 100.00%
a Category 1 transaction
Ordinary Resolution Number 2 195,094,108 0 0 195,094,108
Approval of the implementation of the Remedica 100.00% 0.00% 0.00% 100.00%
Transaction as a Category 1 transaction
Ordinary Resolution Number 3 195,049,785 44,323 0 195,094,108
Authority to sign all documents 99.98% 0.02% 0.00% 100.00%
Votes withheld are not votes in law and have not been counted in the calculation of the proportion of votes 'for' or
'against' a resolution. Proxy appointments which gave discretion to the Chairman have been included in the 'for'
total.
2. Update on Equity Raise
With regards to the funding of the transactions referred to in Ordinary Resolution Number 1 and Ordinary
Resolution Number 2 above, Ascendis can confirm that as announced on SENS on 8 August 2016, the R1.2 billion
rights offer was three times oversubscribed, and the c.R1.5 billion vendor placement was also significantly over
subscribed.
Andy Sims
Company Secretary
Ascendis Health Limited
11 August 2016
Transaction Sponsor
Absa Bank Limited (acting through its Corporate and Investment Bank division)
Corporate Sponsor
Investec Bank Limited
Date: 11/08/2016 12:04:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.